EVITA: a tool for the early EValuation of pharmaceutical Innovations with regard to Therapeutic Advantage
-
* Corresponding author: Bernd Mühlbauer muehlbauer@pharmakologie-bremen.de
BMC Clinical Pharmacology 2010, 10:5 doi:10.1186/1472-6904-10-5
Pre-publication versions of this article and reviewers' reports
| Resubmission - Version 2 | Manuscript | Author's comment | 16 Apr 2009 |
| Reviewer's Report | Richard Entsuah, Ph.D. | 29 May 2009 | |
| Reviewer's Report | Claire LE JEUNNE | 09 Jul 2009 | |
| Reviewer's Report | Claire LE JEUNNE | 10 Jul 2009 | |
| Resubmission - Version 3 | 03 Nov 2009 | ||
| Resubmission - Version 4 | Manuscript | 03 Nov 2009 | |
| Reviewer's Report | Richard Entsuah, Ph.D. | 18 Nov 2009 | |
| Reviewer's Report | Claire LE JEUNNE | 23 Nov 2009 | |
| Resubmission - Version 5 | Manuscript | 03 Dec 2009 | |
| Resubmission - Version 6 | Manuscript | Author's comment | 12 Jan 2010 |
| Editorial acceptance | 05 Feb 2010 | ||
| Published | 16 Mar 2010 |